Eli Lilly will spend at least $27 billion dollars to build four manufacturing plants in the U.S. in order to move production back to America.
NVAX reports encouraging fourth-quarter results. It completes the sale of its Czech Republic manufacturing unit to Novo ...
AstraZeneca has opened a plant to produce biogas from organic waste that will ensure by the end of this year all of its ...
The Moor Bioenergy plant is set to supply 100 gigawatt hours of renewable energy annually to AstraZeneca's British operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback